Showing results (1161-1170 of 3,886) with videos related to
Sort By:
Pageof 389
Cancer Biology & Therapy|August 6, 2005
PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivoFang Tian, Xiongwen Zhang, Yunguang Tong, et al.Cancer Biology & Therapy|August 6, 2005
Psoriasin (S100A7) and calgranulin-B (S100A9) induction is dependent on reactive oxygen species and is downregulated by Bcl-2 and antioxidantsHanna Carlsson, Maria Yhr, Stina Petersson, et al.Cancer Biology & Therapy|August 6, 2005
Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancerHimani Sharma, Sudip Sen, Neeta SinghCancer Biology & Therapy|August 6, 2005
Downregulation of survivin by RNAi inhibits the growth of esophageal carcinoma cellsYihua Wang, Hongxia Zhu, Lanping Quan, et al.Cancer Biology & Therapy|July 5, 2021
Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool?Aleksandra Tarasiuk, Tomasz Mackiewicz, Ewa Małecka-Panas, et al.Cancer Biology & Therapy|July 5, 2021
FGFR2 maintains cancer cell differentiation via AKT signaling in esophageal squamous cell carcinomaOsamu Maehara, Goki Suda, Mitsuteru Natsuizaka, et al.Cancer Biology & Therapy|September 29, 2017
Inactivation of miR-100 combined with arsenic treatment enhances the malignant transformation of BEAS-2B cells via stimulating epithelial -mesenchymal transitionJia Yang, Zhijun Chen, Xinyi Wang, et al.Cancer Biology & Therapy|October 12, 2017
LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4Baoli Hu, Haifeng Zhang, Zuopei Wang, et al.Cancer Biology & Therapy|September 26, 2003
Novel anticancer agents in clinical developmentAlex A Adjei, Eric K RowinskyCancer Biology & Therapy|September 26, 2003
Angiogenesis inhibitors: a new class of drugsJudah FolkmanPageof 389